ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,036Medicare Part D Prescriptions Filled, Including Refills

Rank: 144 out of 2061

$824K Total Retail Price of All Prescriptions

Rank: 220 out of 2061

556 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 556 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 556 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 14,943 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
SIMVASTATIN 666 631 1 1
OMEPRAZOLE 590 565 2 5
LEVOTHYROXINE SODIUM 563 542 3 3
HYDROCODONE-ACETAMINOPHEN 541 466 S3 4 10
FUROSEMIDE 523 471 5 6
LISINOPRIL 453 419 6 2
AMLODIPINE BESYLATE 328 308 7 4
ATORVASTATIN CALCIUM 314 301 8 8
CITALOPRAM HBR 283 266 9 20
ZOLPIDEM TARTRATE 270 240 10 23
POTASSIUM CHLORIDE 263 262 11 16
HYDROCHLOROTHIAZIDE 239 215 12 12
METFORMIN HCL 211 190 13 9
SERTRALINE HCL 197 197 14 21
METOPROLOL TARTRATE 189 189 15 7
ATENOLOL 185 179 16 13
DONEPEZIL HCL 184 181 17 24
POLYETHYLENE GLYCOL 3350 173 173 18 64
LOSARTAN POTASSIUM 172 156 19 17
TAMSULOSIN HCL 149 135 20 30
PRAVASTATIN SODIUM 147 144 21 14
JANTOVEN 142 141 22 93
METOPROLOL SUCCINATE 141 141 23 19
NAMENDA 137 136 24 37
CRESTOR 124 121 25 31
ALLOPURINOL 119 105 26 28
TRAMADOL HCL 118 114 27 18
CYMBALTA 118 92 27 59
TRAZODONE HCL 115 114 29 39
GABAPENTIN 113 112 30 15
PREDNISONE 107 101 31 32
WARFARIN SODIUM 104 90 32 11
NEXIUM 103 73 33 26
OXYCODONE-ACETAMINOPHEN 103 79 S2 33 36
FLUTICASONE PROPIONATE 102 89 35 43
CARVEDILOL 101 86 36 22
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 95 37 27
LOVASTATIN 97 82 38 35
DIGOXIN 96 89 39 56
DIOVAN 95 73 40 41
ALENDRONATE SODIUM 88 88 41 25
CELEBREX 86 84 42 91
OXYCODONE HCL 85 62 S2 43 82
NYSTATIN-TRIAMCINOLONE 84 81 44 224
GLIMEPIRIDE 84 61 44 33
JANUVIA 83 80 46 51
ZETIA 80 80 47 68
FENTANYL 78 78 S2 48 84
CIPROFLOXACIN HCL 78 77 48 54
GLYBURIDE 77 68 R 50 60
IPRATROPIUM-ALBUTEROL 77 77 50 117
PAROXETINE HCL 76 76 52 61
LANTUS SOLOSTAR 72 68 53 76
AZITHROMYCIN 70 62 54 34
CLOPIDOGREL 69 64 55 29
CARBIDOPA-LEVODOPA 68 68 56 97
LIPITOR 68 46 56 70
RISPERIDONE 67 67 58 66
KLOR-CON M20 67 59 58 47
NITROFURANTOIN MONO-MACRO 66 65 60 162
TRIAMTERENE-HCTZ 66 63 60 38
TRIAMTERENE-HYDROCHLOROTHIAZID 66 66 60 135
MIRTAZAPINE 64 64 63 46
MELOXICAM 62 62 64 44
SPIRONOLACTONE 61 49 65 62
FINASTERIDE 60 60 66 86
DIOVAN HCT 59 59 67 99
RANITIDINE HCL 58 50 68 53
PEN NEEDLE 57 52 69 116
AMOXICILLIN 56 53 70 121
SSD 56 56 70 284
ESCITALOPRAM OXALATE 54 53 72 77
METHYLPREDNISOLONE 54 47 72 101
ADVAIR DISKUS 53 53 74 57
HYDROCORTISONE 53 46 74 278
LACTULOSE 52 48 76 131
CEFUROXIME 52 46 76 170
LANTUS 52 50 76 48
LEVETIRACETAM 51 51 79 102
DILTIAZEM 24HR CD 51 51 79 118
PROPRANOLOL HCL 51 40 79 143
LATANOPROST 51 51 79 236
LANSOPRAZOLE 51 42 79 139
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.